drugset / Trial / NCT01039623
Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as Reference
RandomizedParallel-groupOpen-labelPrevention
Summary
Healthy volunteers will be vaccinated against H1N1 pandemic influenza. One group will receive the adjuvant vaccine while the other group will get intradermal antigen, without the adjuvant. The antibody production will be compared.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-12
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pandemrix | Vaccine | — | Other |
Indications
No indication recorded.